Moderna to Present at Upcoming Conferences in September 2025
Moderna (NASDAQ:MRNA) has announced its participation in two major healthcare investor conferences in September 2025. The company will present at the Morgan Stanley's 23rd Annual Global Healthcare Conference on September 8th at 10:00am ET and at Bernstein Insights: Healthcare Leaders and Disruptors on September 25th at 10:30am ET.
Investors can access live webcasts of both presentations through the "Events and Presentations" section of Moderna's investor website. The webcasts will remain archived on the company's website for a minimum of 30 days after each presentation.
Moderna (NASDAQ:MRNA) ha comunicato la sua partecipazione a due importanti conferenze per investitori nel settore sanitario previste a settembre 2025. L'azienda presenterà al Morgan Stanley's 23rd Annual Global Healthcare Conference l'8 settembre alle 10:00 ET e al Bernstein Insights: Healthcare Leaders and Disruptors il 25 settembre alle 10:30 ET.
Gli investitori potranno seguire entrambe le presentazioni in diretta tramite la sezione «Eventi e presentazioni» del sito investor di Moderna. Le webcast resteranno archiviate sul sito della società per almeno 30 giorni dopo ogni presentazione.
Moderna (NASDAQ:MRNA) ha anunciado su participación en dos importantes conferencias para inversores del sector sanitario en septiembre de 2025. La compañía presentará en el Morgan Stanley's 23rd Annual Global Healthcare Conference el 8 de septiembre a las 10:00 ET y en Bernstein Insights: Healthcare Leaders and Disruptors el 25 de septiembre a las 10:30 ET.
Los inversores podrán acceder a las retransmisiones en vivo de ambas presentaciones a través de la sección «Eventos y presentaciones» del sitio web para inversores de Moderna. Las retransmisiones quedarán archivadas en la web de la compañía durante un mínimo de 30 días tras cada presentación.
Moderna (NASDAQ:MRNA)는 2025년 9월에 열리는 두 개의 주요 의료 투자자 컨퍼런스에 참가한다고 발표했습니다. 회사는 Morgan Stanley's 23rd Annual Global Healthcare Conference에서 9월 8일 오전 10:00 ET에 발표하며, Bernstein Insights: Healthcare Leaders and Disruptors에서는 9월 25일 오전 10:30 ET에 발표할 예정입니다.
투자자들은 Moderna 투자자 웹사이트의 "이벤트 및 프레젠테이션" 섹션을 통해 두 발표의 실시간 웹캐스트를 시청할 수 있습니다. 웹캐스트는 각 발표 후 최소 30일 동안 회사 웹사이트에 아카이브로 보관됩니다.
Moderna (NASDAQ:MRNA) a annoncé sa participation à deux grandes conférences pour investisseurs dans le secteur de la santé en septembre 2025. La société présentera lors du Morgan Stanley's 23rd Annual Global Healthcare Conference le 8 septembre à 10h00 ET et lors de Bernstein Insights: Healthcare Leaders and Disruptors le 25 septembre à 10h30 ET.
Les investisseurs pourront accéder aux webcasts en direct des deux présentations via la rubrique « Événements et présentations » du site investisseurs de Moderna. Les webcasts resteront archivés sur le site de la société pendant au moins 30 jours après chaque présentation.
Moderna (NASDAQ:MRNA) hat seine Teilnahme an zwei bedeutenden Investorenkonferenzen im Gesundheitswesen im September 2025 angekündigt. Das Unternehmen wird am Morgan Stanley's 23rd Annual Global Healthcare Conference am 8. September um 10:00 Uhr ET und beim Bernstein Insights: Healthcare Leaders and Disruptors am 25. September um 10:30 Uhr ET präsentieren.
Investoren können beide Präsentationen live über den Bereich „Events and Presentations“ auf Modernas Investorenseite verfolgen. Die Webcasts werden nach jeder Präsentation mindestens 30 Tage lang auf der Website des Unternehmens archiviert.
- None.
- None.
CAMBRIDGE, MA / ACCESS Newswire / August 21, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced its participation in the following upcoming investor conferences:
Morgan Stanley's 23rd Annual Global Healthcare Conference, on Monday, September 8th at 10:00am ET
Bernstein Insights: Healthcare Leaders and Disruptors, on Thursday, September 25th at 10:30am ET
A live webcast of each of these presentations will be available under "Events and Presentations" in the Investors section of the Moderna website.
A replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation.
About Moderna
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.
Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.
Media Contacts
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
FAQ
When is Moderna presenting at the Morgan Stanley Healthcare Conference 2025?
When is Moderna's presentation at the Bernstein Insights conference?
How can investors access Moderna's September 2025 conference presentations?
How long will Moderna's conference webcasts be available for replay?
